Effects of Frailty on Outcomes and 30-day Readmissions After Surgical Mitral Valve Replacement

被引:1
|
作者
Iyengar, Amit
Goel, Nicholas
Kelly, John J.
Han, Jason
Brown, Chase R.
Khurshan, Fabliha
Chen, Zehang
Desai, Nimesh
机构
[1] Univ Penn, Dept Surg, Div Cardiac Surg, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
来源
ANNALS OF THORACIC SURGERY | 2020年 / 109卷 / 04期
关键词
SURGERY; TRANSCATHETER; IMPACT; SURVIVAL; REPAIR;
D O I
10.1016/j.athoracsur.2016.10.087
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Frailty is increasingly recognized as an important prognostic marker in surgical populations. The effects of frailty on outcomes after mitral valve replacement (MVR) is less clear given the inherent complexity of this patient population. We evaluated the influences of frailty on outcomes and readmission rates after MVR. Methods. Adult patients undergoing isolated MVR were queried from the National Readmissions Database from 2010 to 2014. Frailty was defined using the Johns Hopkins Adjusted Clinical Groups frailty-defining diagnoses indicator, a validated instrument developed for use in health administrative data. Multivariable logistic regression was used to determine hospital- and patientlevel risk factors for readmission, postoperative complications, and death. Results. Among 50,410 patients who underwent MVR, 7.9% met frailty criteria. Frail patients were more likely to be older, have nonprivate insurance, an index admission from the emergency department, and teaching hospital care (all P < .001). Frail patients had significantly more postoperative complications (77% vs 47%, P < .001), more discharges to a facility (50% vs 21%, P < .001), and higher in-hospital mortality (12% vs 4%, P < .001). Index hospitalization costs were almost doubled in frail patients, and of those who survived to discharge, 30-day readmissions were more frequent (28% vs 20%, P < .001). Frailty independently increased the risk of index hospitalization composite complications (adjusted odds ratio [AOR], 3.28; 95% confidence interval [CI], 2.61-4.12), in-hospital mortality (AOR, 2.35; 95% CI, 1.90-2.92), and 30-day readmission (AOR, 1.47; 95% CI, 1.20-1.78). Conclusions. Frailty is an independent predictor of morbidity, death, and increased costs after MVR. Frailty metrics should be increasingly understood among patients requiring mitral valve intervention as percutaneous approaches for intervention become increasingly used. (C) 2020 by The Society of Thoracic Surgeons
引用
收藏
页码:1120 / 1126
页数:7
相关论文
共 50 条
  • [1] 30-DAY READMISSIONS AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT
    Patel, Parth
    Gopal, Shwetha
    Hilden, Patrick
    Mistry, Nirav
    CHEST, 2020, 158 (04) : 126A - 126A
  • [2] Causes, Risk Factors, and Costs of 30-Day Readmissions After Mitral Valve Repair and Replacement
    Goel, Nicholas J.
    Iyengar, Amit
    Kelly, John J.
    Brown, Chase R.
    Kurshan, Fabliha
    Atluri, Pavan
    Acker, Michael A.
    Chen, Zehang
    Desai, Nimesh D.
    ANNALS OF THORACIC SURGERY, 2019, 108 (06): : 1729 - 1737
  • [3] Modified Frailty Index is Associated with 30-Day Surgical Readmissions
    Wahl, Tyler S.
    Graham, Laura A.
    Richman, Joshua
    Morris, Melanie S.
    Hollis, Robert H.
    Jones, Caroline E.
    Copeland, Laurel A.
    Itani, Kamal M.
    Burns, Edith A.
    Hawn, Mary T.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2016, 223 (04) : S113 - S113
  • [4] In-Hospital, 30-Day, and 6-Month Outcomes of Valve-in-Valve Transcatheter Mitral Valve Replacement vs Redo Surgical Mitral Valve Replacement
    Ullah, Waqas
    Hashem, Anas
    Khan, Muhammad
    Gowda, Smitha
    Salman, Fnu
    Thakkar, Samarthkumar
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (12) : B214 - B214
  • [5] 30-Day Outcomes of Transseptal Transcatheter Mitral Valve Replacement for Failed Surgical Bioprostheses (Mitral Valve-in-Valve): The MITRAL Trial (Mitral Implantation of TRAnscatheter vaLves)
    Guerrero, Mayra
    Pursnani, Amit
    Salinger, Michael
    Wang, Dee Dee
    Kodali, Susheel
    George, Isaac
    Hahn, Rebecca T.
    Satler, Lowell
    Inglessis, Ignacio
    Eleid, Mackram
    Meduri, Christopher
    Rajagopal, Vivek
    Reisman, Mark
    Aldea, Gabriel
    Eng, Marvin
    Waksman, Ron
    Pichard, Augusto
    Palacios, Igor
    Russell, Hyde M.
    Saucedo, Jorge
    Kar, Saibal
    Makkar, Raj
    O'Neill, William
    Rihal, Charanjit
    Leon, Martin
    Feldman, Ted
    CIRCULATION, 2017, 136
  • [6] 30-Day Outcomes after Surgical or Transapical Aortic Valve Replacement in Symptomatic Aortic Regurgitation
    Kong, Minjian
    Hong, Ze
    Liu, Xianbao
    Zhu, Xian
    Wang, Jianan
    Dong, Aiqiang
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2022, 9 (07)
  • [7] 30 Day Readmissions After Transcatheter Aortic Valve Replacement
    Patel, Parth N.
    Gopal, Shwetha
    Hilden, Patrick
    Mistry, Nirav
    JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : S123 - S123
  • [8] Predictors of 30-day outcomes following mitral valve repair
    Reisman, Adam M.
    Thomas, A. Taylor
    Boateng, Percy
    Leitman, I. Michael
    ANNALS OF MEDICINE AND SURGERY, 2019, 47 : 5 - 12
  • [9] Impact of frailty on outcomes and readmissions after transcatheter and surgical aortic valve replacement in a national cohort
    Miles, Travis J.
    Ryan, Christopher T.
    Hogan, Katie J.
    Sayal, Bhavesh S.
    Sylvester, Christopher B.
    Rosengart, Todd K.
    Coselli, Joseph S.
    Moon, Marc R.
    Ghanta, Ravi K.
    Chatterjee, Subhasis
    JTCVS OPEN, 2024, 20 : 14 - 25
  • [10] OBSERVANT aortic valve replacement score to predict 30-day mortality after surgical aortic valve replacement
    Nezic, Dusko
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2021, 60 (04) : 1002 - 1002